ホーム > 中村 貴之/ NAKAMURA, Yoshiyuki

中村 貴之

NAKAMURA, Yoshiyuki

医学医療系 , 准教授
Faculty of Medicine , Associate Professor
オープンアクセス版の論文は「つくばリポジトリ」で読むことができます。
  1. 1. Efficacy of adjuvant anti-PD-1 antibody versus observation for resected nail apparatus melanoma. Takaya Komori; Eiji Nakano; Yukiko Kiniwa; Shoichiro Mori (+41 著者) Shigeto Matsushita
      Journal of the European Academy of Dermatology and Venereology : JEADV (2026) Semantic Scholar
  2. 2. Phase III Study Investigating the Safety and Efficacy of TM5614 in Combination With Nivolumab for the Treatment of Unresectable Malignant Melanoma: Protocol. Taku Fujimura; Koji Yoshino; Hiroshi Kato; Satoshi Fukushima (+22 著者) Yoshihide Asano
      Experimental dermatology 35: e70202 (2026) Semantic Scholar
  3. 3. Complete response of a metastatic cutaneous apocrine carcinoma under oral S-1 monotherapy. Shoichiro Ishizuki; Yoshiyuki Nakamura; Ko Matsuoka; Yasuhiro FujisawaToshifumi Nomura
      Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 23: 524 (2025) Semantic Scholar
  4. 4. Plate-like osteoma cutis along Blaschko line: A case report and published work review of lesion distribution. Ko Matsuoka; Yoshiyuki Nakamura; Shoichiro Ishizuki; Toshifumi Nomura
      The Journal of dermatology 52: e253-e254 (2025) Semantic Scholar
  5. 5. 自己免疫疾患で生じる皮膚炎の加齢で変化する病態制御機構 大矢 和正; 中村 貴之; 沖山 奈緒子; 藤澤 康弘乃村 俊史
      加齢皮膚医学セミナー 19: 9 (2024)
  6. 6. 自己免疫疾患で生じる皮膚炎の加齢で変化する病態制御機構 大矢 和正; 中村 貴之; 沖山 奈緒子; 藤澤 康弘乃村 俊史
      加齢皮膚医学セミナー 19: 9 (2024)
  7. 7. Dermal injury drives a skin to gut axis that disrupts the intestinal microbiome and intestinal immune homeostasis in mice. Tatsuya Dokoshi; Yang Chen; Kellen J Cavagnero; Gibraan Rahman (+9 著者) Richard L Gallo
      Nature communications 15: 3009 (2024) Semantic Scholar
  8. 8. Soluble PD-L1 predicts tumor response and immune-related adverse events in patients with advanced melanoma treated with anti-PD-1 antibodies. Kazumasa Oya; Yoshiyuki Nakamura; Larina Tzu-Wei Shen; Shoichiro Ishizuki (+1 著者) Yasuhiro Fujisawa
      The Journal of dermatology (2024) Semantic Scholar
  9. 9. Increased LL37 in psoriasis and other inflammatory disorders promotes LDL uptake and atherosclerosis. Yoshiyuki Nakamura; Nikhil N Kulkarni; Toshiya Takahashi; Haleh Alimohamadi (+11 著者) Richard L Gallo
      The Journal of clinical investigation 134: (2024) Semantic Scholar
  10. 10. Viral afterlife: SARS-CoV-2 as a reservoir of immunomimetic peptides that reassemble into proinflammatory supramolecular complexes. Yue Zhang; Vanthana Bharathi; Tatsuya Dokoshi; Jaime de Anda (+30 著者) Gerard C L Wong
      Proceedings of the National Academy of Sciences of the United States of America 121: e2300644120 (2024) Semantic Scholar
  11. 11. Role of Sentinel Lymph Node Biopsy for Skin Cancer Based on Clinical Studies. Shoichiro Ishizuki; Yoshiyuki Nakamura
      Cancers 15: (2023) Semantic Scholar
  12. 12. Eribulin mesylate exerts antitumor effects via CD103. Kazumasa Oya; Yoshiyuki Nakamura; Rei Watanabe; Ryota Tanaka (+7 著者) Yasuhiro Fujisawa
      Oncoimmunology 12: 2218782 (2023) Semantic Scholar
  13. 13. The Role of PD-L1 on Langerhans Cells in the Regulation of Psoriasis. Ryota Tanaka; Yuki Ichimura; Noriko Kubota; Risa Konishi (+5 著者) Naoko Okiyama
      The Journal of investigative dermatology 142: 3167 (2022) Semantic Scholar
  14. 14. Prognoses of patients with melanoma who continue/discontinue anti-programmed death-1 therapy after achieving a complete response in a real-world setting: a multicentre retrospective study Junji Kato; Kenjiro Namikawa; Jiro Uehara; Motoo Nomura (+13 著者) Naoya Yamazaki
      British Journal of Dermatology 187: 594 (2022) Semantic Scholar
  15. 15. Concordance in judgment of clinical borders of basal cell carcinomas in Japanese patients: A preliminary study of JCOG2005 (J-BASE-MARGIN). Anna Kamimura; Yasuhiro Nakamura; Tatsuya Takenouchi; Shigeto Matsushita (+42 著者) Naoya Yamazaki
      The Journal of dermatology 49: 837 (2022) Semantic Scholar
  16. 16. Evidence from Clinical Studies Related to Dermatologic Surgeries for Skin Cancer. Shoichiro Ishizuki; Yoshiyuki Nakamura
      Cancers 14: (2022) Semantic Scholar
  17. 17. Enfortumab vedotin‐induced cutaneous adverse events manifesting as miliaria‐like eruptions with the presence of keratinocyte apoptosis in clinically intact skin K. Oya; Y. Nakamura; K. Iwamoto; T. Kimura (+2 著者) Y. Fujisawa
      Journal of the European Academy of Dermatology and Venereology 36: (2022) Semantic Scholar
  18. 18. Response to ‘Clinical and direct immunofluorescence characteristics of cutaneous toxicity associated with enfortumab vedotin’ Kazumasa Oya; Yoshiyuki Nakamura; Yasuhiro Fujisawa; Toshifumi Nomura
      British Journal of Dermatology 187: 275 (2022) Semantic Scholar
  19. 19. Keratinocyte apoptosis was present in clinically intact skin in a patient treated with enfortumab vedotin. Kazumasa Oya; Yoshiyuki Nakamura; Tomokazu Kimura; Hiroyuki NishiyamaYasuhiro Fujisawa
      European journal of cancer (Oxford, England : 1990) 167: 172 (2022) Semantic Scholar
  20. 20. Unilateral areolar leiomyoma with sebaceous hyperplasia. Kazumasa Oya; Yoshiyuki Nakamura; Yasuhiro Fujisawa
      Indian journal of dermatology, venereology and leprology 88: 536 (2022) Semantic Scholar
1 2 3 … 9

書籍等出版物情報はまだありません。

講演・口頭発表情報はまだありません。

 406 total views